Related Experiment Video
Updated: Aug 14, 2026
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells
Haruhito Azuma1, Shogo Ehata, Hideyo Miyazaki
1Department of Urology, Osaka Medical College, Takatsuki, Osaka, Japan.
Background:
Transforming growth factor beta (TGF-beta) facilitates metastasis during the advanced stages of cancer. Smad6, Smad7, and c-Ski block signaling by the TGF-beta superfamily proteins through different modes of action. We used adenovirus-mediated gene transfer of these natural inhibitors in a mouse model of breast cancer to examine the roles of TGF-beta superfamily signaling in tumor growth and metastasis.
Methods:
We systemically administered, by intravenous injection, adenoviruses (AdCMV) containing the mouse cDNAs for Smad7, Smad6, c-Ski, the c-Ski mutant c-Ski (ARPG), or LacZ (control) to nude mice (>19 mice/group) bearing tumors derived from mouse mammary carcinoma JygMC(A) cells, which spontaneously metastasize to lung and liver, and examined their effects on survival and metastasis. High-throughput western blotting analysis was used to examine the expression levels for 47 signal transduction proteins in JygMC(A) cells and primary tumors. We also investigated the proliferation, migration, and invasion of JygMC(A) cells that stably overexpressed Smad6 or Smad7. Nonparametric comparisons were done by Kruskal-Wallis H statistic and Wilcoxon's rank sum tests. Parametric comparisons were done by one-way analysis of variance or two-sided unpaired Student's t tests. All statistical tests were two-sided.
Results:
Control mice bearing tumors derived from JygMC(A) cells showed many metastases to the lung and liver; all animals died by 50 days after cell inoculation. By contrast, mice treated with AdCMV-Smad7 or AdCMV-c-Ski demonstrated a dramatic decrease in metastasis and statistically significantly longer survival than control mice (Smad7 versus LacZ: medium survival = 55 days versus 41 days, difference = 14 days [95% confidence interval {CI} = 6 days to 22 days], P < .001), whereas mice treated with AdCMV-Smad6 or AdCMV-c-Ski (ARPG) did not. Expression of Smad7 in JygMC(A) cells was associated with increased expression of major components of adherens and tight junctions, including E-cadherin, decreased expression of N-cadherin, and decreases in the migratory and invasive abilities of the JygMC(A) cells.
Conclusion:
Smad7 inhibits metastasis, possibly by regulating cell-cell adhesion. Systemic expression of Smad7 may be a novel strategy for the prevention of metastasis of advanced cancers.
Insights
Smad7 significantly reduced metastasis and prolonged survival in a mouse breast cancer model. This suggests systemic Smad7 expression could be a novel strategy against advanced cancer spread.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metastasis
Background:
- Transforming growth factor beta (TGF-beta) signaling is crucial for advanced cancer metastasis.
- Smad6, Smad7, and c-Ski are natural inhibitors of TGF-beta superfamily signaling.
- Investigating these inhibitors' roles in breast cancer metastasis is essential.
Purpose of the Study:
- To evaluate the efficacy of Smad6, Smad7, and c-Ski gene transfer in a mouse model of breast cancer metastasis.
- To determine the impact of these inhibitors on tumor growth, survival, and metastasis.
- To explore the molecular mechanisms underlying Smad7's effect on metastasis.
Main Methods:
- Adenovirus-mediated gene transfer of Smad7, Smad6, c-Ski, and a c-Ski mutant (ARPG) into mice with JygMC(A) mammary carcinoma.
- Systemic administration via intravenous injection, with LacZ as a control.
- Analysis of survival, metastasis, protein expression (high-throughput western blotting), and cell migration/invasion assays.
Main Results:
- Systemic Smad7 and c-Ski administration significantly reduced lung and liver metastasis and prolonged survival compared to controls.
- Smad7 treatment led to increased expression of adherens and tight junction proteins (e.g., E-cadherin) and decreased N-cadherin.
- Smad7 overexpression reduced the migratory and invasive capabilities of JygMC(A) cells.
Conclusions:
- Smad7 effectively inhibits breast cancer metastasis, potentially by enhancing cell-cell adhesion.
- Systemic Smad7 expression presents a promising novel therapeutic strategy for preventing metastasis in advanced cancers.
